SCHEMBL571479

SCHEMBL571479

CC(C)OC(=O)C(O)(C(C)C)C(O)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
TSHR P16473 1/20 0.34
TP53 P04637 1/20 0.33
HCAR2 Q8TDS4 1/20 0.32
CPT2 P23786 1/20 0.31
ACLY P53396 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20775589 1.00 MEN1 (0.36) MEN1KMT2ATSHRTP53HCAR2
SCHEMBL2244400 0.82 MEN1 (0.37) MEN1KMT2ATSHRHCAR2
SCHEMBL2246646 0.82 MEN1 (0.37) MEN1KMT2ATSHRHCAR2
SCHEMBL2815553 0.76 CPT2 (0.41) TSHRTP53CPT2ACLY
SCHEMBL8106901 0.74 RNPEP (0.34) MEN1KMT2ATSHR
SCHEMBL20564587 0.73 TSHR (0.48) MEN1KMT2ATSHRHCAR2
SCHEMBL7240623 0.69 TSHR (0.43) MEN1KMT2ATSHRHCAR2
SCHEMBL26324855 0.69 TSHR (0.43) MEN1KMT2ATSHRHCAR2
SCHEMBL235499 0.66 TSHR (0.46) MEN1KMT2ATSHRHCAR2
SCHEMBL448528 0.66 TSHR (0.46) MEN1KMT2ATSHRHCAR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 814 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260144726-A1 POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER L'OREAL (FR) 2026-05-28 US claimed
CN-119638969-A Degradable aromatic polyester polymer and synthesis method thereof 青岛大学 2025-03-18 CN claimed
CN-119016001-A Micro-reaction system and method for synthesizing bio-based polyol 中建安装集团有限公司 2024-11-26 CN claimed
CN-115505108-B Hydrolysis-resistant titanium catalyst and preparation method and application thereof 中国石油化工股份有限公司 2024-08-30 CN claimed
CN-117603047-B Preparation method and application of bio-based polyol 中建安装集团有限公司 2024-06-11 CN claimed
CN-115650787-B Liquid compositions containing urease inhibitors 甘肃云昊科技有限公司 2024-03-29 CN claimed
CN-117603047-A Preparation method and application of bio-based polyol 中建安装集团有限公司 2024-02-27 CN claimed
CN-117402113-A Production method of 8-hydroxyquinoline copper 苏州华道生物药业股份有限公司 2024-01-16 CN claimed
CN-116178432-A Novel preparation method of fosfomycin sodium 鼎元(天津)生物医药科技有限公司 2023-05-30 CN claimed
CN-113402461-B Method for preparing guaiazupyridine type sesquiterpene alkaloid 中国科学院新疆理化技术研究所 2023-02-03 CN claimed
EP-0515142-B1 Optically active epoxides and a process for the production thereof CHISSO CORP (JP) 1996-10-23 EP claimed
US-5310956-A From alkenyl ethylene glycols, titanium tetraalkoxide, dialkyl tartrate, a peroxide, epoxidation CHISSO CORPORATION (JP) 1994-05-10 US claimed
US-5216002-A Using benzyl substituted rhodanine derivatives as pure enantiomeric form ELI LILLY AND COMPANY (US) 1993-06-01 US claimed
EP-0515142-A1 Optically active epoxides and a process for the production thereof CHISSO CORPORATION (JP) 1992-11-25 EP claimed
US-5112990-A Oxidation of cyclic sulfites produced from dihydroxy compounds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1992-05-12 US claimed
EP-0434394-A2 Compounds for treating inflammatory bowel disease ELI LILLY AND COMPANY (US) 1991-06-26 EP claimed
EP-0417187-A1 RUTHENIUM-CATALYZED PRODUCTION OF CYCLIC SULFATES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1991-03-20 EP claimed
WO-1989011478-A1 RUTHENIUM-CATALYZED PRODUCTION OF CYCLIC SULFATES MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1989-11-30 WO claimed
WO-1988001612-A1 PROCESSES AND INTERMEDIATES FOR N-(S-3-ALKYL-HEPTANOYL)-D-GAMMA-GLUTAMYL-GLYCYL-D-ALANINE PFIZER INC. (US) 1988-03-10 WO claimed
EP-0258032-A2 Processes and intermediates for N-(S-3-alkylheptanoyl)-D-gamma-glutamyl-glycyl-D-alanine PFIZER INC. (US) 1988-03-02 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260144726-A1 POLYOL-FREE COSMETIC COMPOSITION COMPRISING ALPHA HYDROXY ACID ESTER HAO2, HADH, LDHA MEN1 2466/4885KMT2A 2037/4885TSHR 1891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.